A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia
Clinical trial NCT02780726 · COMPLETED
Trial details
- NCT number
- NCT02780726
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-22
- Primary completion
- 2017-08-02
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.